• A human factors validation study showed that both adults and adolescents could successfully administer NaxSwab™ OTC in a simulated opioid overdose emergency.
• The study included participants with varying literacy levels, demonstrating the usability of NaxSwab™ OTC across different demographics.
• NaxSwab™ OTC exhibited faster naloxone absorption compared to intramuscular naloxone and naloxone spray in earlier pharmacokinetic studies.
• Pocket Naloxone Corp. aims to make NaxSwab™ OTC affordable and accessible to combat opioid overdose deaths.